187 related articles for article (PubMed ID: 2924067)
21. Mibefradil- and omega-conotoxin GVIA-induced inhibition of noradrenaline release from the sympathetic nerves of the human heart.
Göthert M; Molderings GJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):860-3. PubMed ID: 9453476
[TBL] [Abstract][Full Text] [Related]
22. Significant role of neuronal non-N-type calcium channels in the sympathetic neurogenic contraction of rat mesenteric artery.
Tanaka Y; Mochizuki Y; Tanaka H; Shigenobu K
Br J Pharmacol; 1999 Dec; 128(7):1602-8. PubMed ID: 10602342
[TBL] [Abstract][Full Text] [Related]
23. Omega-conotoxin GVIA specifically blocks neuronal mechanisms in rat ileum.
Allescher HD; Willis S; Schusdziarra V; Classen M
Neuropeptides; 1989; 13(4):253-8. PubMed ID: 2546090
[TBL] [Abstract][Full Text] [Related]
24. Inhibition by omega-conotoxin GVIA of adrenal catecholamine release in response to endogenous and exogenous acetylcholine.
Kimura T; Takeuchi A; Satoh S
Eur J Pharmacol; 1994 Oct; 264(2):169-75. PubMed ID: 7851479
[TBL] [Abstract][Full Text] [Related]
25. Two types of high-threshold calcium currents inhibited by omega-conotoxin in nerve terminals of rat neurohypophysis.
Wang X; Treistman SN; Lemos JR
J Physiol; 1992 Jan; 445():181-99. PubMed ID: 1323666
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a neurogenic and a direct smooth muscle component in the contractile response to electrical field stimulation in rat tail artery.
Szabó C; Hardebo JE
J Auton Pharmacol; 1990 Oct; 10(5):283-96. PubMed ID: 1964679
[TBL] [Abstract][Full Text] [Related]
27. Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release.
Dooley DJ; Lupp A; Hertting G; Osswald H
Eur J Pharmacol; 1988 Mar; 148(2):261-7. PubMed ID: 3378575
[TBL] [Abstract][Full Text] [Related]
28. Noradrenaline release from rat sympathetic neurones triggered by activation of B2 bradykinin receptors.
Boehm S; Huck S
Br J Pharmacol; 1997 Oct; 122(3):455-62. PubMed ID: 9351501
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of central neurotransmitter release by omega-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel.
Dooley DJ; Lupp A; Hertting G
Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):467-70. PubMed ID: 2448660
[TBL] [Abstract][Full Text] [Related]
30. Role of N-, P- and Q-type voltage-gated calcium channels in transmitter release from sympathetic neurones in the mouse isolated vas deferens.
Waterman SA
Br J Pharmacol; 1997 Feb; 120(3):393-8. PubMed ID: 9031741
[TBL] [Abstract][Full Text] [Related]
31. Presynaptic alpha2-receptors regulate reverse Na+/Ca2+-exchange and transmitter release in Na+-loaded peripheral sympathetic nerves.
Török TL; Nagykáldi Z; Sáska Z; Kovács T; Nada SA; Zilliikens S; Magyar K; Sylvester Vizi E
Neurochem Int; 2004 Oct; 45(5):699-711. PubMed ID: 15234113
[TBL] [Abstract][Full Text] [Related]
32. Influence of age on control of norepinephrine release: Ca2+ channels and dopamine D2 receptors.
Friedman DJ; Duckles SP
Eur J Pharmacol; 1994 Jan; 252(1):1-9. PubMed ID: 7908641
[TBL] [Abstract][Full Text] [Related]
33. N-type and P/Q-type calcium channels regulate differentially the release of noradrenaline, ATP and beta-NAD in blood vessels.
Smyth LM; Yamboliev IA; Mutafova-Yambolieva VN
Neuropharmacology; 2009 Feb; 56(2):368-78. PubMed ID: 18824011
[TBL] [Abstract][Full Text] [Related]
34. Omega-conotoxin GVIA inhibits release of noradrenaline from rat hippocampal slices in the absence of extracellular calcium.
Huang HY
Neuropharmacology; 1993 Feb; 32(2):133-7. PubMed ID: 8450942
[TBL] [Abstract][Full Text] [Related]
35. Increased Ca2+ sensitivity of alpha 1-adrenoceptor-stimulated contraction in SHR caudal artery.
Aqel MB; Sharma RV; Bhalla RC
Am J Physiol; 1986 Feb; 250(2 Pt 1):C275-82. PubMed ID: 2420189
[TBL] [Abstract][Full Text] [Related]
36. Involvement of different calcium channels in the depolarization-evoked release of noradrenaline from sympathetic neurones in rabbit carotid artery.
Uhrenholt TR; Nedergaard OA
Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):109-14. PubMed ID: 15998358
[TBL] [Abstract][Full Text] [Related]
37. Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue.
Kurz T; Richardt G; Hagl S; Seyfarth M; Schömig A
J Mol Cell Cardiol; 1995 May; 27(5):1161-72. PubMed ID: 7473774
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological evidence that tetraethylammonium-sensitive, iberiotoxin-insensitive K+ channels function as a negative feedback element for sympathetic neurotransmission by suppressing omega-conotoxin-GVIA-insensitive Ca2+ channels in the relaxation of rabbit facial vein.
Tanaka Y; Akutsu A; Tanaka H; Horinouchi T; Tsuru H; Koike K; Shigenobu K
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):35-42. PubMed ID: 12616339
[TBL] [Abstract][Full Text] [Related]
39. [Ca
Hansen T; Tarasova OS; Khammy MM; Ferreira A; Kennard JA; Andresen J; Staehr C; Brain KL; Nilsson H; Aalkjaer C
Acta Physiol (Oxf); 2019 Aug; 226(4):e13279. PubMed ID: 30957955
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of transmitter release from sympathetic nerve endings by omega-conotoxin.
Brock JA; Cunnane TC; Evans RJ; Ziogas J
Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):333-9. PubMed ID: 2568204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
